title: Normal hematologic parameters and fetal hemoglobin silencing with heterozygous IKZF1 mutations.
authors: Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA.|Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.|Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.
authors: Nour
authors: N
authors: Abdulhay
authors: Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA.|Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.|Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.
authors: Claudia
authors: C
authors: Fiorini
authors: ARUP Institute for Clinical and Experimental Pathology, ARUP Laboratories, Salt Lake City, UT.|Department of Pathology, University of Utah, Salt Lake City, UT.
authors: Attila
authors: A
authors: Kumánovics
authors: Immunology Service, Department of Laboratory Medicine, Clinical Center, and Primary Immune Deficiency Clinic, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and.
authors: Ashleigh A
authors: AA
authors: Sun
authors: ARUP Institute for Clinical and Experimental Pathology, ARUP Laboratories, Salt Lake City, UT.|Department of Pathology, University of Utah, Salt Lake City, UT.|Departments of Pediatrics and Medicine, University of Utah, Salt Lake City, UT.
authors: Jeannette
authors: J
authors: Hansen-Rejali
authors: ARUP Institute for Clinical and Experimental Pathology, ARUP Laboratories, Salt Lake City, UT.|Department of Pathology, University of Utah, Salt Lake City, UT.
authors: Karl V
authors: KV
authors: Voelkerding
authors: Department of Pathology, University of Utah, Salt Lake City, UT.
authors: Sergio D
authors: SD
authors: Rosenzweig
authors: ARUP Institute for Clinical and Experimental Pathology, ARUP Laboratories, Salt Lake City, UT.|Department of Pathology, University of Utah, Salt Lake City, UT.|Departments of Pediatrics and Medicine, University of Utah, Salt Lake City, UT.
authors: Harry R
authors: HR
authors: Hill
authors: Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA.|Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.|Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.
authors: Vijay G
authors: VG
authors: Sankaran
mesh_terms: D000328:Adult; D002648:Child; D002675:Child, Preschool; D017074:Common Variable Immunodeficiency / Q000097:blood / Q000235:genetics*; D005190:Family; D005260:Female; D005319:Fetal Hemoglobin / Q000235:genetics*; D020868:Gene Silencing / Q000502:physiology; D006579:Heterozygote; D006801:Humans; D051740:Ikaros Transcription Factor / Q000235:genetics*; D008297:Male; D020125:Mutation, Missense; D010375:Pedigree
chemical_list: C497239:IKZF1 protein, human; D051740:Ikaros Transcription Factor; D005319:Fetal Hemoglobin